Management of autoimmune hepatitis

Area of Science:

• Hepatology
• Immunology
• Clinical Medicine

Background:

• Autoimmune hepatitis (AIH) is a chronic, progressive liver disease with variable activity.
• Early research in the 1970s confirmed steroid effectiveness, but a research lull occurred later.
• Increasing recognition of treatment challenges and diagnostic complexities spurred renewed research efforts.

Purpose of the Study:

• To review recent significant discoveries in autoimmune hepatitis (AIH) treatment.
• To highlight advancements pertinent to the clinical management of AIH patients.
• To provide an update on AIH research following a period of limited study.

Main Methods:

• Literature review of recent AIH treatment research.
• Analysis of data supporting second-line therapies.
• Consideration of findings from a large-scale budesonide vs. prednisone trial.

Main Results:

• Development of a clinically useful short-form diagnostic scoring system for AIH.
• Growing evidence supports mycophenolate and tacrolimus as effective second-line treatments.
• Completion of a major trial comparing budesonide to prednisone in AIH treatment.

Conclusions:

• Recent findings are highly relevant to the daily clinical practice for AIH patients.
• New diagnostic and therapeutic insights are enhancing AIH management.
• The renaissance in AIH research is yielding practical clinical benefits.